• Directory of Taiwan

Urinary Tract Cancer Market Size, Share, growth, Trends and Forecast 2021-2030

Report Ocean presents a new report on urinary cancer market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the market’s future.

The global urinary cancer market is forecast to grow at a compound annual growth rate (CAGR) of more than 18% during the forecast period from 2021-2030, and the market value anticipates to reach USD 8700 million by 2030.

Request To Download Sample of This Strategic Report:-

Cancer of the urinary tract more commonly affects the urethra, bladder, or renal pelvis. Cystoscopy is the gold standard procedure for the diagnosis of bladder cancer. Another technology, computed tomography (CT) urography, is used in macroscopic hematuria in order to obtain images of the upper urinary tract. There is no known cause of urinary tract cancer, but overuse of catheterized bladders, smoking, chronic inflammation in the urinary tract, and exposure to carcinogenic chemicals are factors that may lead to the development of the disease.

Factors Affecting

The increasing prevalence of bladder cancer is an essential factor driving growth in the world’s urinary tract cancer market; the increase in funding from private & government sources for studies, growth in the geriatric population, and growth in R&D activities in healthcare.

During the forecast period, the geriatric population is likely to fuel the market’s growth. In elderly individuals, fewer immune cells fight against the cancer tissue in the bladder, making them more prone to urinary tract cancer. A report by the American society of clinical oncology (ASCO) indicated that, as of January 2021, approximately 90% of individuals with bladder cancer are older than 55 years of age. As per the American Cancer Society, 2019, smoking combined with workplace exposure can lead to bladder cancer.

The rising number of approvals for the treatment of urinary tract cancer, the increase in sedentary lifestyles such as smoking, and the rise in exposure to the chemical industry contribute to its growth.

In the forecast period, the risk associated with medications prescribed for urinary tract cancer, such as irritation in the bladder, blood in urine, and infection, is anticipated to restrain the market growth.

Impact Analysis of COVID-19

In the past, the COVID-19 outbreak had negatively impacted the global market for urinary tract cancer. The number of outpatient beds at hospitals and cancer centers is declining, as they focus on selecting only those who require a cystoscopy. It results in the cancellation of many non-essential surgical procedures around the world.

Request To Download Sample of This Strategic Report:-

Regional Overview

This market has a dominant position in North America and is forecast to remain so during the forecast period due to the rising prevalence of bladder cancer, increase in healthcare expenditures, the existence of key players, availability of advanced cancer treatments, and advancements in R&D activities in the healthcare sector in the region. However, Asia-Pacific anticipates registering the highest CAGR from 2022 to 2030 due to a rise in urinary tract cancer prevalence, an increasing number of smokers, the government’s initiatives, and a growing elderly population.

Leading Companies

The leading prominent companies in the global urinary tract cancer market are:

Astellas Pharma Inc. (Japan)

Bristol-Myers Squibb Company (U.S.)

Eli Lily and Company (U.S.)

Endo International plc. (Europe)

Exelixis, Inc. (U.S.)

GlaxoSmithKline Plc. (GSK) (United Kingdom)

Merck KGaA (Germany)

Novartis AG (Europe)

Pfizer Inc. (U.S.)

Johnson & Johnson (U.S.)

Other Prominent Players

Scope of the Report

The urinary tract cancer market segmentation focuses on Cancer Type, Treatment Type, Distribution Channel, and Region.

Segmentation based on Cancer Type

Bladder Cancer

Urethral cancer

Ureteric and Renal Pelvic Cancer

Segmentation based on Treatment Type


Retail Pharmacy

Online Pharmacy


Retail Pharmacy

Online Pharmacy

Segmentation based on Distribution Channel

Retail Pharmacy

Online Pharmacy

Get a Sample PDF copy of the report:-

Segmentation based on Region

North America

The U.S.




Western Europe

The UK





Rest of Western Europe

Eastern Europe



Rest of Eastern Europe

Asia Pacific




Australia & New Zealand


Rest of Asia Pacific

Middle East & Africa (MEA)


Saudi Arabia

South Africa

Rest of MEA

South America



Rest of South America

What are the aspects of this report that relate to regional analysis?

The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
How are the key players in the market assessed?
This report provides a comprehensive analysis of leading competitors in the market.
The report includes information about the key vendors in the market.
The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.
The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.
A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.

Access full Report Description, TOC, Table of Figure, Chart, etc.-

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)